Unusual case of vitiligo reversal in Vogt-Koyanagi-Harada syndrome.
作者信息
Subudhi Praveen, Khan Zahiruddin, Subudhi B Nageswar Rao, Sitaram Silla
机构信息
Retina Clinic, Ruby Eye Hospital, Berhampur, Ganjam, Odisha; Department of Ophthalmology, Hitech Medical College, Bhubaneswar, Odisha, India.
Department of Ophthalmology, Hitech Medical College, Bhubaneswar, Odisha, India.
出版信息
Indian J Ophthalmol. 2017 Sep;65(9):867-868. doi: 10.4103/ijo.IJO_336_17.
Abstract
摘要
相似文献
1
Unusual case of vitiligo reversal in Vogt-Koyanagi-Harada syndrome.
Indian J Ophthalmol. 2017 Sep;65(9):867-868. doi: 10.4103/ijo.IJO_336_17.
2
Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Can J Ophthalmol. 2014 Apr;49(2):e54-6. doi: 10.1016/j.jcjo.2014.01.002.
3
Vogt-Koyanagi-Harada disease in 3-year-old boy.
Clin Exp Ophthalmol. 2015 Aug;43(6):593-4. doi: 10.1111/ceo.12512. Epub 2015 Jun 30.
4
Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Am J Ophthalmol. 2002 Sep;134(3):454-6. doi: 10.1016/s0002-9394(02)01575-1.
5
Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
JAMA Ophthalmol. 2020 May 1;138(5):e191981. doi: 10.1001/jamaophthalmol.2019.1981. Epub 2020 May 14.
6
Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Digit J Ophthalmol. 2016 Jun 28;22(2):54-7. doi: 10.5693/djo.02.2015.05.004. eCollection 2016.
7
RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Retina. 2016 Feb;36(2):415-21. doi: 10.1097/IAE.0000000000000728.
8
Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
Can J Ophthalmol. 2009 Apr;44(2):211-2. doi: 10.3129/i09-011.
9
Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
Ophthalmologica. 1999;213(3):197-9. doi: 10.1159/000027419.
10
Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Am J Ophthalmol. 2004 Mar;137(3):572-4. doi: 10.1016/j.ajo.2003.08.035.
本文引用的文献
1
Interventions for Vitiligo.
JAMA. 2016 Oct 25;316(16):1708-1709. doi: 10.1001/jama.2016.12399.
2
Understanding mechanisms of autoimmunity through translational research in vitiligo.
Curr Opin Immunol. 2016 Dec;43:81-88. doi: 10.1016/j.coi.2016.09.008. Epub 2016 Oct 17.
3
Diagnosis and classification of Vogt-Koyanagi-Harada disease.
Autoimmun Rev. 2014 Apr-May;13(4-5):550-5. doi: 10.1016/j.autrev.2014.01.023. Epub 2014 Jan 15.
4
Reversal of poliosis and vitiligo following Vogt-Koyanagi-Harada disease.
Arch Ophthalmol. 2012 Mar;130(3):394-6. doi: 10.1001/archopthalmol.2011.1520.
5
Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
Retina. 2010 Jul-Aug;30(7):1113-21. doi: 10.1097/IAE.0b013e3181c96a87.
6
Global variation and pattern changes in epidemiology of uveitis.
Indian J Ophthalmol. 2007 May-Jun;55(3):173-83. doi: 10.4103/0301-4738.31936.
Zotero 插件